Cancer Screening Center, National Cancer Center Hospital, Tokyo, Japan.
Division of Screening Technology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Am J Gastroenterol. 2019 Jun;114(6):964-973. doi: 10.14309/ajg.0000000000000261.
Because of the increasing number of detected diminutive colorectal adenomas, the "diagnose-and-do-not-resect" approach has recently attracted attention as an alternative to resection. We evaluated the cumulative incidence of advanced colorectal neoplasia (ACN) in individuals with untreated diminutive adenomas and compared this incidence in individuals without adenomas.
Data from 1,378 individuals who underwent first screening colonoscopy (CS) and at least one follow-up CS without polypectomy were analyzed. Patients with no adenomas or with only nonadvanced diminutive adenomas (<5 mm) diagnosed by magnifying image-enhanced endoscopy were scheduled to undergo a follow-up CS within 5 years after the initial CS without treatment. The participants were divided into 2 groups: those with untreated diminutive adenomas (group A) and those with no adenomas (group B). The cumulative incidence of ACN and the hazard ratio were assessed using Gray's test and the Fine and Gray model.
During the median follow-up period of 60.9 months, 21 ACNs were detected. The 5-year cumulative incidences of ACN in group A (n = 361) and group B (n = 1,017) were 1.4% (95% confidence interval [CI]: 0.5-3.4) and 0.8% (95% CI: 0.3-1.7), respectively, without a statistically significant difference (P = 0.23). No ACNs developed from unresected adenomas. The smoking status was significantly associated with the incidence of ACN, and the hazard ratio for ACN in group A vs group B adjusted for smoking status was 1.43 (95% CI: 0.52-3.90; P = 0.48).
The low 5-year cumulative incidence of ACN suggests the potential to adopt the "diagnose-and-do-not-resect" strategy as an alternative option for diminutive adenomas not requiring excessive surveillance.
由于检测到的小尺寸结直肠腺瘤数量不断增加,“诊断而不切除”的方法最近作为切除的替代方法引起了关注。我们评估了未经治疗的小腺瘤患者中晚期结直肠肿瘤(ACN)的累积发生率,并将其与无腺瘤患者进行了比较。
分析了 1378 名接受首次筛查结肠镜检查(CS)和至少一次无息肉切除的后续 CS 的患者的数据。通过放大图像增强内镜诊断为无腺瘤或仅诊断为非进展性小腺瘤(<5mm)的患者,计划在初始 CS 后 5 年内无需治疗即行后续 CS。将患者分为两组:未经治疗的小腺瘤组(A 组)和无腺瘤组(B 组)。采用 Gray 检验和 Fine-Gray 模型评估 ACN 的累积发生率和风险比。
在中位随访 60.9 个月期间,共发现 21 例 ACN。A 组(n=361)和 B 组(n=1017)5 年 ACN 的累积发生率分别为 1.4%(95%置信区间 [CI]:0.5-3.4)和 0.8%(95% CI:0.3-1.7),差异无统计学意义(P=0.23)。未切除的腺瘤未发展为 ACN。吸烟状态与 ACN 的发生显著相关,调整吸烟状态后,A 组与 B 组相比,ACN 的风险比为 1.43(95% CI:0.52-3.90;P=0.48)。
低的 5 年 ACN 累积发生率表明,对于不需要过度监测的小腺瘤,可以采用“诊断而不切除”的策略作为替代方案。